Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Tirzepatide is a newer synthetic peptide that binds two incretin receptors at once: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide)
It was more common at higher doses
Lilly has completed several large diabetes trials and has announced plans to seek a type 2 diabetes indication soon
At 68 weeks, average weight loss ranged from 10.2% with the lowest dose to 17.4% with the highest maintenance dose
Lets walk through what each one does, how theyre prescribed, and which option fits which kind of patient
US$ 26.70
US$ 20.23
US$ 22.54
